Egypt, South Africa sign MoU to cooperate in pharmaceuticals field

Ahram Online , Monday 10 Jul 2023

The Egyptian Drug Authority (EDA) has signed a memorandum of understanding with the South Africa Health Products Regulatory Authority (SAHPRA) that supports collaboration between the two countries in pharmaceuticals, especially Hepatitis C products.

Egypt, South Africa sign MoU to cooperate in medical preparations field (Photo: The Egyptian Drug Authority EDA)


According to the EDA  statement on Monday, the step aims to “increase the collaboration between the two countries in pharmaceuticals, especially Hepatitis C products and antivirals, biological products, and medical devices.”

The agreement, signed on Monday at the Egyptian Embassy in Pretoria, intends to foster a synergistic relationship where both regulators share knowledge and engage in areas of market authorization, pharmacovigilance, Good Manufacturing Practices (GMP), and clinical trials, noted the statement.

This came within the framework of the Egyptian Drug Authority's keenness to cooperate with African countries in the field of medical preparations and supplies, exchange experiences and support cadres working in the field of medicine, and support the entry of Egyptian medical preparations into regional and global markets, the EDA added.

The delegations of both authorities launched a comprehensive dialogue to exchange visions on a wide range of topics of mutual concern. They also discussed practical approaches to deepening relations between both countries in the field of the pharmaceutical industry.

EDA Chairman, Dr Tamer Essam, stressed that this MOU will pave the way for setting a unified vision and coordinating effective dialogue between African countries. It will also support exchanging experiences in the field of pharmaceutical industries in a way that accords with the directives of the Egyptian political leadership to support joint African work.

During the meeting, SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, explained that the step shows commitment and drive to seek collaboration and knowledge sharing with African counterparts.

The Ambassador of Egypt, Ahmed El-Fadly, expressed his satisfaction with the signature of the MoU, indicating that it helps remove one main non-tariff barrier to facilitating trade between both countries in the pharmaceutical sector, which consequently enhances people-to-people relations. The onus, El-Fadly said, is now on relevant business communities in both countries to make the most of this significant development.

Short link: